
Biocon Limited has informed the Exchange regarding a press release dated February 05, 2024, titled "Oral Cancer Task Force's Consensus Guidelines for Head & Neck Cancer Recognized Among 13 Worldwide Clinical Practice Guidelines".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated February 05, 2024, titled "Oral Cancer Task Force's Consensus Guidelines for Head & Neck Cancer Recognized Among 13 Worldwide Clinical Practice Guidelines".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon